This is the blog for CARG, the Coronary Artery Rehabilitation Group, based in Saskatoon, Saskatchewan, Canada. It will contain items of interest to CARG's own members and anybody else interested in the latest news about rehabilitation and heart-related matters. Canadian charitable number: 89675 0163 RR 0001 || e-mail: carg.ca@gmail.com || website: carg.ca || Blog disclaimer
Tuesday, June 28, 2011
Canadian research shows promise in Type 1 diabetes fight
New Canadian research is offering new hope for the fight against Type 1 diabetes after studies have shown a natural chemical in the body can have regenerative effects on the insulin-producing cells that are killed at the onset of the disease. The findings, based out of St. Michael's Hospital in Toronto, suggest treatment using GABA - a natural chemical produced by pancreatic beta cells, which are critical for the production of insulin - can have a reversal effect of the disease and allows the body to better accept the regenerated cells. Roughly 70 per cent of the insulin-producing beta cells are destroyed by the immune system in people who have Type 1 diabetes. The study, however, found that GABA - which is available as an oral dose - protects and regenerates those beta cells and had a reversal effect in diabetic mice. The study, which was published in the Proceedings of the National Academy of Sciences, found that GABA served two key functions in diabetic mice - it regenerates beta cells, but also suppresses autoimmunity, which allows them to remain active in the body
Monday, June 27, 2011
Type 2 diabetes in newly diagnosed 'can be reversed' (UK)
Sunday, June 26, 2011
Diabetes rate 'doubles' - Imperial College and Harvard research suggests
Saturday, June 11, 2011
Circulation journal to launch new series focusing on prevention of cardiovascular disease (AHA)
Circulation: Journal of the American Heart Association has launched a year-long themed series that will focus on the prevention of cardiovascular disease (CVD). The series highlights the importance of preventive strategies as a first-line strategy in the fight against CVD and the impact of behavioral and complementary interventions in reducing the CVD burden. Preventive Cardiology and Lifestyle Medicine will feature monthly review papers by leading cardiology experts exploring new insights in preventive cardiology, lifestyle interventions and cardiac rehabilitation
Heart failure risk lower in women who often eat baked/broiled fish (AHA)
The risk of developing heart failure was lower for postmenopausal women who frequently ate baked or broiled fish, but higher for those who ate more fried fish, in a study reported in Circulation: Heart Failure, an American Heart Association journal. In a large-scale analysis, women who ate the most baked/broiled fish (five or more servings/week) had a 30 percent lower risk of heart failure compared to women who seldom ate it (less than one serving/month). Previous research has found that fatty acids (omega-3) in fish - EPA, DHA and ALA - may lower risk of cardiovascular disease by decreasing inflammation, resisting oxidative stress and improving blood pressure, cardiac and blood vessel function. This study showed that they type of fish and cooking method may affect heart failure risk. The researchers found that dark fish (salmon, mackerel and bluefish) were associated with a significantly greater risk reduction than either tuna or white fish (sole, snapper and cod). In a similar analysis, eating fried fish was associated with increased heart failure risk. Even one serving a week was associated with a 48 percent higher heart failure risk
FDA announces new safety recommendations for high-dose simvastatin (USA)
The U.S. Food and Drug Administration is announcing safety label changes for the cholesterol-lowering medication simvastatin because the highest approved dose - 80 milligram (mg) - has been associated with an elevated risk of muscle injury or myopathy, particularly during the first 12 months of use. The agency is recommending that simvastatin 80 mg be used only in patients who have been taking this dose for 12 months or more and have not experienced any muscle toxicity. It should not be prescribed to new patients. There are also new contraindications and dose limitations for when simvastatin is taken with certain other medications
Stroke is Urgent - Heart and Stroke Foundation's 2011 Stroke Month Report
The Heart and Stroke Foundation's 2011 Stroke Month Report warns that awareness levels of stroke warning signs and stroke prevention is dangerously low, especially among women from Canada's two largest visible minorities - people of Chinese and South Asian descent
BHF-BACPR "Celebrating Cardiac Rehabilitation" Award 2011 (UK)
Nicotine treatment 'could control obesity'
Thursday, June 9, 2011
Drug makes hearts repair themselves (UK)
Thursday, June 2, 2011
Frequent travellers have high obesity risk (USA)
A new study from Columbia University in the United States shows that you are 92% likely to be obese if you are a frequent traveller. In a study of 13,000 people which includes non-travellers as well as frequent business travellers the analysis showed that Body Mass Index (BMI), which is the accepted measurement for obesity, rises significantly if you travel for 14 days or more in a month. And these trends are also reflected in differences in blood pressure and cholesterol
Heart attack fear 'may worsen outcome', study suggests
People with an intense fear of dying during a heart attack could suffer a worse outcome, research suggests. London-led researchers asked 208 patients to rate their levels of fear following a severe cardiac event. People who reported they were most distressed during an attack had higher levels of chemical markers - linked to inflammation - in their blood. Writing in the European Heart Journal, the authors say heightened inflammation may lead to poorer long-term health. "Large inflammatory responses are known to be damaging to the heart, and to increase the risk of longer-term cardiac problems such as having another heart attack," said British Heart Foundation professor of psychology, Andrew Steptoe. The research, led by a team at Imperial College, found that patients who reported an intense fear of dying had raised levels of TNF alpha - a marker that has been linked to inflammatory processes in the body
Subscribe to:
Posts (Atom)